{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:26:12Z","timestamp":1778585172734,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T00:00:00Z","timestamp":1449619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ijid.2015.12.008","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T16:18:34Z","timestamp":1450196314000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Antimicrobial susceptibility and emerging resistance determinants ( bla CTX-M , rmtB , fosA3 ) in clinical isolates from urinary tract infections in the Bolivian Chaco"],"prefix":"10.1016","volume":"43","author":[{"given":"Alessandro","family":"Bartoloni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samanta","family":"Sennati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Di Maggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Mantella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Riccobono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Strohmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Revollo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Liz","family":"Villagran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Pallecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2015.12.008_bib0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drup.2014.02.001","article-title":"Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors","volume":"17","author":"Bonelli","year":"2014","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2015.12.008_bib0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bjid.2013.10.005","article-title":"Extended spectrum beta-lactamase producers among nosocomial Enterobacteriaceae in Latin America","volume":"18","author":"Guzm\u00e1n-Blanco","year":"2014","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0240","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1017\/S095026881300191X","article-title":"Resistant Gram-negative infections in the outpatient setting in Latin America","volume":"141","author":"Salles","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2015.12.008_bib0245","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bjid.2013.07.002","article-title":"Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)","volume":"17","author":"Jones","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0250","series-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.ijid.2015.12.008_bib0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijid.2014.12.006","article-title":"Methicillin-resistant Staphylococcus aureus in hospitalized patients from the Bolivian Chaco","volume":"30","author":"Bartoloni","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0260","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijid.2012.11.017","article-title":"Low prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in urban and rural community settings in Bolivia and Peru","volume":"17","author":"Bartoloni","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0265","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1469-0691.2012.03807.x","article-title":"Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America","volume":"19","author":"Bartoloni","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2015.12.008_bib0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/mdr.2011.0003","article-title":"Carriage of antibiotic-resistant Escherichia coli among healthy children and home-raised chickens: a household study in a resource-limited setting","volume":"18","author":"Riccobono","year":"2012","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijid.2015.12.008_bib0275","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3201\/eid1402.070138","article-title":"Increasing resistance in commensal Escherichia coli, Bolivia and Peru","volume":"14","author":"Bartoloni","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0280","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3201\/eid1206.051258","article-title":"Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia","volume":"12","author":"Bartoloni","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0285","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/382191","article-title":"High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption","volume":"189","author":"Bartoloni","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0290","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-3156.1998.00201.x","article-title":"Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia","volume":"3","author":"Bartoloni","year":"1998","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijid.2015.12.008_bib0295","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijmm.2013.02.008","article-title":"CTX-M-type beta-lactamases: a successful story of antibiotic resistance","volume":"303","author":"D\u2019Andrea","year":"2013","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0300","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.00026-07","article-title":"Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America","volume":"51","author":"Pallecchi","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0305","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1128\/AAC.48.12.4556-4561.2004","article-title":"Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru","volume":"48","author":"Pallecchi","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0310","series-title":"Performance standards for antimicrobial disk susceptibility tests. CLSI document M02-A12","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.ijid.2015.12.008_bib0315","series-title":"Performance standards for antimicrobial susceptibility testing. CLSI supplement M100-S25","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.ijid.2015.12.008_bib0320","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and\/or colistin","volume":"54","author":"Endimiani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0325","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1128\/JCM.01982-13","article-title":"Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC \u03b2-lactamase in a neonatal intensive care unit","volume":"51","author":"Arena","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0330","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1128\/JCM.03361-13","article-title":"Modified CLSI extended-spectrum \u03b2-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various \u03b2-lactamases","volume":"52","author":"Poulou","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0335","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/JCM.01094-14","article-title":"Practical agar-based disk potentiation test for detection of fosfomycin-nonsusceptible Escherichia coli clinical isolates producing glutathione S-transferases","volume":"52","author":"Nakamura","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0340","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.50.2.618-624.2006","article-title":"CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY\/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy","volume":"50","author":"D\u2019Andrea","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0345","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/AAC.05104-11","article-title":"Dissemination of the fosfomycin resistance gene fosA3 with CTX-M \u03b2-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China","volume":"56","author":"Hou","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0350","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijantimicag.2014.02.003","article-title":"Revised and updated multiplex PCR targeting acquired 16S rRNA methyltransferases","volume":"43","author":"Corr\u00eaa","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2015.12.008_bib0355","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1128\/AAC.00915-06","article-title":"Prevalence in the United States of aac(6\u2032)-Ib-cr encoding a ciprofloxacin-modifying enzyme","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0360","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1128\/AEM.66.10.4555-4558.2000","article-title":"Rapid and simple determination of the Escherichia coli phylogenetic group","volume":"66","author":"Clermont","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0365","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/AAC.01604-13","article-title":"Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010","volume":"57","author":"Banerjee","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0370","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/cid\/cit503","article-title":"Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans","volume":"57","author":"Colpan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0375","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jac\/dkp194","article-title":"Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains","volume":"64","author":"Clermont","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2015.12.008_bib0380","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1469-0691.2007.01852.x","article-title":"Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline","volume":"14","author":"Garau","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2015.12.008_bib0385","series-title":"Informe anual de la red de monitoreo\/vigilancia de la resistencia a los antibi\u00f3ticos","author":"Pan-American Health Organization","year":"2010"},{"key":"10.1016\/j.ijid.2015.12.008_bib0390","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0395","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/cid\/cir637","article-title":"Uncomplicated UTI IDSA Guideline Committee. Managing uncomplicated urinary tract infection\u2014making sense out of resistance data","volume":"53","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkq415","article-title":"Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain","volume":"66","author":"Rogers","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0405","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/lam.12366","article-title":"Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli","volume":"60","author":"Ma","year":"2015","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0410","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drup.2012.05.001","article-title":"Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update","volume":"15","author":"Wachino","year":"2012","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2015.12.008_bib0415","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jac\/dkr466","article-title":"Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens","volume":"67","author":"Karageorgopoulos","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/518605","article-title":"16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides","volume":"45","author":"Doi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.12.008_bib0425","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/AAC.01477-07","article-title":"Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America","volume":"52","author":"Fritsche","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0430","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2015.12.008_bib0435","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fmicb.2014.00688","article-title":"F33: A-: B-, IncHI2\/ST3, and IncI1\/ST71 plasmids drive the dissemination of fosA3 and blaCTX-M-55\/-14\/-65 in Escherichia coli from chickens in China","volume":"5","author":"Yang","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijid.2015.12.008_bib0440","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/mdr.2013.0061","article-title":"First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan","volume":"19","author":"Sato","year":"2013","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijid.2015.12.008_bib0445","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1128\/AAC.01834-09","article-title":"Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes","volume":"54","author":"Wachino","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2015.12.008_bib0450","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1469-0691.2011.03636.x","article-title":"Fosfomycin: an old-new antibiotic","volume":"18","author":"Raz","year":"2012","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215002891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971215002891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T20:30:42Z","timestamp":1537129842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971215002891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":45,"alternative-id":["S1201971215002891"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2015.12.008","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2015.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}